Appili Therapeutics Inc stock dipped on Monday.
In today's trading, Appili Therapeutics Inc shares closed at $0.07 after opening the day at $0.07. Intraday prices ranged from $0.07 to $0.07.
The price shrank -7.14% from the previous day's close of $0.07.
Today across North America, the TSX Composite closed 0.22% at 19620.13, the S&P 500 closed -0.16% at 4145.19, the Dow Jones Industrial Average closed 0.23% at 32803.47 and the Nasdaq Composite closed -0.50% at 12657.55.
Appili Therapeutics Inc has listed on the TSX stock exchange under the ticker APLI.TO.
Trading volume was 23,000 on 2 total trades, while having an average volume of 59,124 over 5 days.
Trading across the entire TSX saw 3,396 price advancers against 2,222 declines and 245 unchanged.
During the prior 52 weeks, APLI.TO has traded as high as $1.14 (September 30,2021) and low as $0.06 (July 22,2022). Moreover, in the last 52 weeks, Appili Therapeutics Inc's shares have plummeted -91.22%, while this year, they have shrunken -43.48%.
Following today's trading, Appili Therapeutics Inc has a market capitalization of $8.49 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.38.
Appili Therapeutics Inc is a None company headquartered in Halifax, US.
Appili Therapeutics Inc's average recommendation is "Hold" based on 2.00 analysts according to Zacks. Currently, there are 2 hold ratings for the stock.
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..